Search Within

Carol A Aghajanian

Formats
  1. Journal Article (325)
  2. Meeting Abstract (284)
  3. Review (3)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (615)
  2. GDMT, Medicine (615)
  3. Gynecologic Medicine Service (615)
  4. Gynecology Disease Management Team (615)
  5. Solid Tumor Oncology Division (615)
  6. Surgery (229)

More Groups

People
  1. Nadeem Abu-Rustum (126)
  2. Paul Sabbatini (125)
  3. Alexia Iasonos (116)
  4. David Spriggs (105)
  5. Roisin O'Cearbhaill (99)
  6. Martee Hensley (94)

More People

Years
  1. 2025 (24)
  2. 2024 (38)
  3. 2023 (42)
  4. 2022 (45)
  5. 2021 (35)
  6. 2020 (61)

More Years

Publications
  1. Gynecologic Oncology (200)
  2. Journal of Clinical Oncology (150)
  3. International Journal of Gynecological Cancer (57)
  4. Clinical Cancer Research (30)
  5. Annals of Oncology (28)
  6. Cancer (15)

More Publications

Publishers
  1. Elsevier B.V. (204)
  2. American Society of Clinical Oncology (156)
  3. Lippincott Williams & Wilkins (59)
  4. American Association for Cancer Research (54)
  5. Oxford University Press (30)
  6. Elsevier Inc. (21)

More Publishers

Results (615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation of immunohistochemistry with TP53 sequence and clinical outcomes in GOG-086P
    Meeting Abstract

    Thiel, K. W.; Devor, E. J.; Filiaci, V.; Levine, D. A.; Dao, F.; Olvera, N.; Mutch, D.; Aghajanian, C.; Leslie, K. K.
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study
    Journal Article

    Leslie, K. K.; Filiaci, V. L.; Mallen, A. R.; Thiel, K. W.; Devor, E. J.; Moxley, K.; Richardson, D.; Mutch, D.; Alvarez Secord, A.; Tewari, K. S.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary study
    Journal Article

    Boerner, T.; Walch, H. S.; Nguyen, B.; Iasonos, A.; Zhou, Q. C.; Schultz, N.; Chui, M. H.; Grisham, R. N.; Tew, W. P.; O'Cearbhaill, R. E.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers
    Journal Article

    Rubinstein, M. M.; Grisham, R. N.; Cadoo, K.; Kyi, C.; Tew, W. P.; Friedman, C. F.; O'Cearbhaill, R. E.; Zamarin, D.; Zhou, Q.; Iasonos, A.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Pattern of disease in recurrent cervical cancer associated with response to pembrolizumab
    Meeting Abstract

    Miller, K.; Filippova, O. T.; Hayes, S. A.; Abu-Rustum, N.; Aghajanian, C.; Broach, V.; Ellenson, L. H.; Jewell, E. L.; Kyi, C.; Lakhman, Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Basket study of the oral progesterone antagonist onapristone ER in women with progesterone receptor positive (PR plus ) recurrent granulosa cell tumor (GCT), low-grade serous ovarian cancer (LGSOC), or endometrioid endometrial cancer (EEC)
    Meeting Abstract

    Grisham, R. N.; Li, K.; Iasonos, A.; Girshman, J.; Cadoo, K. A.; Kyi, C.; Makker, V.; Cohen, S. M.; O'Cearbhaill, R. E.; Sabbatini, P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Germline mutation prevalence in young adults with cancer
    Meeting Abstract

    Stadler, Z. K.; Maio, A.; Padunan, A.; Kemel, Y.; Salo-Mullen, E.; Sheehan, M.; Belanfanti, K.; Tejada, P. R.; Birsoy, O.; Mandelker, D.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Distant metastatic spread and clonal evolution of high-grade endometrial cancers
    Meeting Abstract

    Miller, K.; Selenica, P.; Reis-Filho, J.; Abu-Rustum, N. R.; Makker, V.; Aghajanian, C. A.; Iacobuzio-Donahue, C. A.; Murali, R.; Weigelt, B.
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Postprogression efficacy outcomes from the phase 3 ARIEL3 study of rucaparib in patients with platinum-sensitive recurrent ovarian carcinoma associated with either BRCA1 or BRCA2 mutations
    Meeting Abstract

    Weberpals, J.; Oza, A.; Lorusso, D.; Scambia, G.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Clamp, A. R.; Leary, A.; more...
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent chemonaive stromal ovarian tumors
    Meeting Abstract

    Brown, J.; Miller, A.; Moxley, K.; Backes, F.; Nagel, C.; Bender, D.; Miller, D.; Powell, M.; Westin, S.; Bonebrake, A.; more...
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save